1-11 of 11
Charles Shapiro
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Abstract RF02-01: A Multicenter, Phase I/II Trial of Anastrozole, Palbociclib, Trastuzumab, and Pertuzumab in Hormone Receptor (HR)-Positive, HER2-Positive Metastatic Breast Cancer (ASPIRE)

Rima Patel, Krystal Cascetta, Paula Klein, Erin Moshier, Maryann Kwa, Julie Fasano, Anupama Goel, Melissa Accordino, Charles Shapiro, Rita Vaccaro, Gargi Atul Joshi, Joseph Sparano, Amy Tiersten
Journal: Cancer Research
Cancer Res (2024) 84 (9_Supplement): RF02-01.
https://doi.org/10.1158/1538-7445.SABCS23-RF02-01
Published: 02 May 2024
View article titled, Abstract RF02-01: A Multicenter, Phase I/II Trial of Anastrozole, Palbociclib, Trastuzumab, and Pertuzumab in Hormone Receptor (HR)-Positive, HER2-Positive Metastatic Breast Cancer (ASPIRE)
Journal Articles

Abstract PO2-06-07: A Randomized Phase II Comparison of Single-Agent Carboplatin versus the Combination of Carboplatin and Everolimus for the Treatment of Advanced Triple Negative Breast Cancer

Rima Patel, Jami Fukui, Paula Klein, Erin Moshier, Charles Shapiro, Anupama Goel, Julie Fasano, Theresa Shao, Aarti Bhardwaj, Rita Vaccaro, Gargi Atul Joshi, Joseph Sparano, Amy Tiersten
Journal: Cancer Research
Cancer Res (2024) 84 (9_Supplement): PO2-06-07.
https://doi.org/10.1158/1538-7445.SABCS23-PO2-06-07
Published: 02 May 2024
View article titled, Abstract PO2-06-07: A Randomized Phase II Comparison of Single-Agent Carboplatin versus the Combination of Carboplatin and Everolimus for the Treatment of Advanced Triple Negative Breast Cancer
Journal Articles

Abstract CT262: Multicenter, phase I/II trial of anastrozole, palbociclib, trastuzumab, and pertuzumab in HR-positive, HER2-positive metastatic breast cancer

Krystal Pauline Cascetta, Poulikos Poulikakos, Charles Shapiro, Julie Fasano, Aarti Bhardwaj, Hanna Irie, Anupama Goel, Paula Klein, Meng Ru, Amy Tiersten
Journal: Cancer Research
Cancer Res (2020) 80 (16_Supplement): CT262.
https://doi.org/10.1158/1538-7445.AM2020-CT262
Published: 15 August 2020
View article titled, Abstract CT262: Multicenter, phase I/II trial of anastrozole, palbociclib, trastuzumab, and pertuzumab in HR-positive, HER2-positive metastatic breast cancer
Journal Articles

Abstract LB-216: NCI 9455: Phase II study of trametinib followed by trametinib plus AKT inhibitor,GSK2141795 in patients with advanced triple negative breast cancer

Bhuvaneswari Ramaswamy, Ewa Mrozek, Maryam Lustberg, Robert Wesolowski, Rachel Layman, Mahmoud Abdel-Rasoul, Cynthia Timmers, Robyn Patrick, Jennifer Sexton, Erin Macrae, Charles Shapiro, Thomas Budd, Lyndsay Harris, Claudine Isaacs, Roohi Ismail-Khan, Claire Dees, Andrew Poklepovic, Micheal Grever, Helen Chen, Miguel Villalona, William Carson
Journal: Cancer Research
Cancer Res (2016) 76 (14_Supplement): LB-216.
https://doi.org/10.1158/1538-7445.AM2016-LB-216
Published: 15 July 2016
View article titled, Abstract LB-216: NCI 9455: Phase II study of trametinib followed by trametinib plus AKT inhibitor,GSK2141795 in patients with advanced triple negative breast cancer
Journal Articles

Abstract P2-03-03: Incidence of actionable genomic alterations in metastatic breast cancer: A prospective study

Raquel E Reinbolt, Katlyn Tolliver, Mahmoud Abdel-Rasoul, Cynthia Timmers, Bhuvaneswari Ramaswamy, Rachel M Layman, Robert Wesolowski, Maryam B Lustberg, Ewa Mrozek, Susan Ottman, James Chen, Charles Shapiro, Michael C Ostrowski, Gustavo W Leone, Erin Macrae
Journal: Cancer Research
Cancer Res (2015) 75 (9_Supplement): P2-03-03.
https://doi.org/10.1158/1538-7445.SABCS14-P2-03-03
Published: 01 May 2015
View article titled, Abstract P2-03-03: Incidence of actionable genomic alterations in metastatic breast cancer: A prospective study
Journal Articles

Abstract P1-09-04: Longitudinal evaluation of taxane-induced neuropathy in early stage breast cancer

Maryam B Lustberg, Scott Monfort, Janani Singaravelu, Raquel E Reinbolt, Xueliang Pan, Bhuvaneswari Ramaswamy, Rachel M Layman, Robert Wesolowski, Ewa Mrozek, Erin Macrae, Charles Shapiro, Robyn Patrick, Charles L Loprinzi, Ajit Chaudhari
Journal: Cancer Research
Cancer Res (2015) 75 (9_Supplement): P1-09-04.
https://doi.org/10.1158/1538-7445.SABCS14-P1-09-04
Published: 01 May 2015
View article titled, Abstract P1-09-04: Longitudinal evaluation of taxane-induced neuropathy in early stage breast cancer
Journal Articles

RAGE Mediates S100A7-Induced Breast Cancer Growth and Metastasis by Modulating the Tumor Microenvironment

Mohd W. Nasser, Nissar Ahmad Wani, Dinesh K. Ahirwar, Catherine A. Powell, Janani Ravi, Mohamad Elbaz, Helong Zhao, Laura Padilla, Xiaoli Zhang, Konstantin Shilo, Michael Ostrowski, Charles Shapiro, William E. Carson, III, Ramesh K. Ganju
Journal: Cancer Research
Cancer Res (2015) 75 (6): 974–985.
https://doi.org/10.1158/0008-5472.CAN-14-2161
Published: 12 March 2015
View article titled, RAGE Mediates S100A7-Induced Breast Cancer Growth and Metastasis by Modulating the Tumor Microenvironment
Open the PDF for RAGE Mediates S100A7-Induced Breast Cancer Growth and Metastasis by Modulating the Tumor Microenvironment in another window
Includes: Supplementary data
Journal Articles

Abstract 1122: In vivo NCL-targeting affects breast cancer aggressiveness through miRNA regulation.

Dario Palmieri, Luciana De Luca, Jessica Consiglio, Alberto Rocci, Tiffany Talabere, Claudia Piovan, Alessandro Lagana, Luciano Cascione, Jingwen Guan, Pierluigi Gasparini, Veronica Balatti, Vincenzo Coppola, Craig Hofmeister, Guido Marcucci, John Byrd, Stefano Volinia, Charles Shapiro, Michael Freitas, Carlo Croce, Flavia Pichiorri
Journal: Cancer Research
Cancer Res (2013) 73 (8_Supplement): 1122.
https://doi.org/10.1158/1538-7445.AM2013-1122
Published: 15 April 2013
View article titled, Abstract 1122: In vivo NCL-targeting affects breast cancer aggressiveness through miRNA regulation.
Journal Articles

Abstract 4044: Epigenetic repression of RARRES1 is mediated by methylation of a critical proximal promoter and a loss of CTCF binding

Huey-Jen L. Lin, Zhengang Peng, Rulong Shen, Yingwei Li, Kun-Yu Teng, Charles Shapiro
Journal: Cancer Research
Cancer Res (2012) 72 (8_Supplement): 4044.
https://doi.org/10.1158/1538-7445.AM2012-4044
Published: 15 April 2012
View article titled, Abstract 4044: Epigenetic repression of <em>RARRES1</em> is mediated by methylation of a critical proximal promoter and a loss of CTCF binding
Journal Articles

Abstract #LB-56: Suppression of anti-tumor immunity by E2F3

Hui Wang, Hui-Zi Chen, Lizhao Wu, Alain de Bruin, Melissa House, Stanley Ng, Jackie Johnson, Larry Goldenberg, Xiaohuang Fang, Soledad Fernandez, Julie Stephens, Shan Naidu, Paul Stromberg, Thomas Rosol, Charles Shapiro, Gustavo Leone
Journal: Cancer Research
Cancer Res (2009) 69 (9_Supplement): LB-56.
Published: 01 May 2009
View article titled, Abstract #LB-56: Suppression of anti-tumor immunity by E2F3
Journal Articles

Estrogen-mediated epigenetic silencing of receptor type protein phosphatase (PTPRO) in breast cancer and its potential role in tamoxifen resistance

Sarmila Majumder, Bhuvaneswari Ramaswamy, Tasneem Motiwala, Huban Kutay, Charles Shapiro, Samson Jacob
Journal: Cancer Research
Cancer Res (2007) 67 (9_Supplement): 3684.
Published: 01 May 2007
View article titled, Estrogen-mediated epigenetic silencing of receptor type protein phosphatase (PTPRO) in breast cancer and its potential role in tamoxifen resistance